Literature DB >> 9632108

Early alterations of actin cytoskeleton in OK cells by opioids.

E A Papakonstanti1, E Bakogeorgou, E Castanas, D S Emmanouel, R Hartig, C Stournaras.   

Abstract

Recently we identified and characterized opioid binding sites in OK (opossum kidney) cells and observed decreased proliferation of these cells in response to opioids. In the present study we investigated the effects of opioids on the actin cytoskeleton and explored whether their antiproliferative action may relate to alterations in the distribution or the dynamics of actin microfilaments. Exposure of OK cells to the opioids alphaS1 casomorphin and ethylketocyclazocine resulted in a rapid and substantial actin microfilament reorganization. This was documented by a significant dose-dependent decrease in the amounts of F-actin, determined by measurements of quantitative fluorescence, by immunoblot analysis and by a concomitant increase of the G/total-actin ratio measured by the DNase I inhibition assay. These changes were verified by confocal laser scanning microscopy, which showed marked redistribution of the microfilamentous structures in the presence of the opioids without affecting the organization of microtubules or vimentin intermediate filaments. The effect of opioids on actin polymerization dynamics occurred within 15 min and persisted for at least 2 h, while their restoration to control levels was accomplished 6 h later, indicating a reversible phenomenon. Northern blot analysis showed that the concentration of the actin transcript was unaffected. The addition of diprenorphine, a general opioid antagonist, prevented the effects of opioids on the actin cytoskeleton. The inhibition of OK cell proliferation, induced by ethylketocyclazocine and alphaS1 casomorphin was partially prevented in the presence of phallacidin, which stabilizes microfilaments. Our findings demonstrate that opioids, acting via kappa 1 binding sites, induce rapidly modifications in the dynamics of actin polymerization, and in the organization of microfilaments in OK cells, which may relate to their antiproliferative effect on these cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632108     DOI: 10.1002/(sici)1097-4644(19980701)70:1<60::aid-jcb7>3.0.co;2-1

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase.

Authors:  S B Koukouritaki; E A Vardaki; E A Papakonstanti; E Lianos; C Stournaras; D S Emmanouel
Journal:  Mol Med       Date:  1999-06       Impact factor: 6.354

2.  Testosterone induced apoptosis in colon cancer cells is regulated by PI3K/Rac1 signaling.

Authors:  Saad Alkahtani
Journal:  Asian J Androl       Date:  2013-06-17       Impact factor: 3.285

3.  Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization.

Authors:  Evangelia A Papakonstanti; Christos Stournaras
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

4.  Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain.

Authors:  M Julia García-Fuster; Marcel Ferrer-Alcón; Antonio Miralles; Jesús A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

5.  A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts.

Authors:  Olga Rassouli; George Liapakis; Iakovos Lazaridis; George Sakellaris; Kostas Gkountelias; Achille Gravanis; Andrew N Margioris; Katia P Karalis; Maria Venihaki
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

6.  Phosphoproteome Profiling of SH-SY5y Neuroblastoma Cells Treated with Anesthetics: Sevoflurane and Isoflurane Affect the Phosphorylation of Proteins Involved in Cytoskeletal Regulation.

Authors:  Joomin Lee; Eunsook Ahn; Wyun Kon Park; Seyeon Park
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.